Open label placebo to treat fatigue in people with multiple sclerosis: feasibility and preliminary effects

Open label placebo to treat fatigue in people with multiple sclerosis: feasibility and preliminary effects

Abstract Background Fatigue is highly prevalent in adults with multiple sclerosis (MS) and current treatments offer limited benefit. It has been speculated that placebos only have an effect when they are administered with deception and concealment, which is unethical in clinical practice. Recent stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Navneet Kaur Baidwan, Tracy Tracy, Chia-Ying Chiu, Tanjila Nawshin, Teri Hoenemeyer, Emily Riser, Robert Motl, Kevin Fontaine, Tapan Mehta
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Pilot and Feasibility Studies
Subjects:
Multiple sclerosis
Fatigue
Open-label placebo
Online Access:https://doi.org/10.1186/s40814-025-01674-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40814-025-01674-w

Similar Items